Cargando…
Identification of Non-Electrophilic Nrf2 Activators from Approved Drugs
Oxidative damage can lead to a wide range of diseases. Nrf2 is an important transcription factor that regulates many of the cytoprotective enzymes involved in the oxidative stress response. Therefore, targeting the regulation of Nrf2 activation is one logical and effective strategy to prevent or low...
Autores principales: | Zhang, Qing-Ye, Chu, Xin-Yi, Jiang, Ling-Han, Liu, Meng-Yuan, Mei, Zhi-Ling, Zhang, Hong-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152778/ https://www.ncbi.nlm.nih.gov/pubmed/28587109 http://dx.doi.org/10.3390/molecules22060883 |
Ejemplares similares
-
Identification of NUDT5 Inhibitors From Approved Drugs
por: Tong, Xin-Yu, et al.
Publicado: (2020) -
Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate
por: Satoh, Takumi, et al.
Publicado: (2017) -
Targeting Cytokine Release Through the Differential Modulation of Nrf2 and NF-κB Pathways by Electrophilic/Non-Electrophilic Compounds
por: Fagiani, Francesca, et al.
Publicado: (2020) -
Electrophiles against (Skin) Diseases: More Than Nrf2
por: Hennig, Paulina, et al.
Publicado: (2020) -
Therapeutic advantage of pro-electrophilic drugs to activate the Nrf2/ARE pathway in Alzheimer's disease models
por: Lipton, Stuart A, et al.
Publicado: (2016)